Bender v. Allegra

130 F.3d 990, 39 Fed. R. Serv. 3d 809, 1997 U.S. App. LEXIS 34315, 1997 WL 753599
Court of Appeals for the Eleventh Circuit·Decided December 8, 1997·No. 95-9418·Published·Cited by 2 cases

Opinions

HATCHETT, Chief Judge:

Appellants, class members of a federal securities lawsuit that concluded in a settlement, moved, after final judgment had been entered, “to enforce” the settlement agreement, asserting state-law- claims against ap-pellees for alleged misconduct occurring during the period of the settlement negotiations. The district court, finding that appellants’ motion constituted a contractually-prohibited attempt to modify the settlement agreement, held that it had “no authority or jurisdiction” to entertain it. We affirm.

BACKGROUND

On August 24, 1994, the district court in the Northern District of Georgia certified a class of persons (appellants) who purchased T2 Medical, Inc. (T2) common stock from December 2, 1991, through August 12, 1993, and “suffered damages as a result thereof.”1 Less than two months later, the parties executed a memorandum of understanding which memorialized the material terms of a settlement.

In April 1995, the parties filed a stipulation of settlement with the district court. The stipulation provides that appellants release and discharge all claims against appellees in exchange for $25,000,000 and 2,520,000 warrants to purchase Coram common stock. The adjusted exercise price of the warrants, calculated pursuant to a formula outlined in paragraph 2.3 of the stipulation, was $22.1252 Paragraph 9.7 of the stipulation states that

[t]his Stipulation of Settlement ... shall not be subject to limitation, impairment, modification, or termination for any reason ..., including without limitation the following:
(a) Any judicial ... decision ... of any type which allegedly relates to any of the terms of this settlement or to any issue, claim, allegation or defense which has been or might have been asserted in the Litigation;
[992] (b) Any change, whether adverse or positive, in the financial condition, assets, liabilities, business, or any other corporate ... activity of any of the Parties;
(c) Any allegedly newly discovered facts, legal issues, events or allegations of any type which allegedly relate to any of the terms of this settlement ...; or
(d) Any other action or conduct of any type which allegedly relates to any of the terms of this settlement....

Paragraph 10.7 of the stipulation provides that the stipulation and its exhibits “constitute the entire agreement among the parties hereto and no representations, warranties or inducements have been made to any party concerning the Stipulation ... other than the representations, warranties and covenants contained and memorialized in such documents.” Paragraph 10.10 of the stipulation reads: “The Court shall retain jurisdiction with respect to implementation and enforcement of the terms of the Stipulation, and the Settling Parties hereto submit to the jurisdiction of the Court for purposes of implementing and enforcing the settlement embodied in the Stipulation.”

After conducting a fairness hearing, on May 19, 1995, the district court, in a Final Judgment and Order of Dismissal, approved the “settlement set forth in the Stipulation,” and “direct[ed] that it ... be effectuated in accordance with its terms.” The court also wrote:

Without affecting the finality of this Judgment in any way, this Court hereby retains continuing jurisdiction over (a) implementation and administration of the settlement; (b) distribution of the Settlement Fund; (c) determination of any questions or applications for attorneys’ fees, costs, interest, and expenses; (d) determination of any other applications for payments out of the Settlement Fund; and (e) all parties heretofore [sic] the purpose of enforcing and administering the Stipulation and Exhibits thereto and the Litigation until the Judgment contemplated hereby has become effective and each and every act agreed to be performed by the parties has been performed pursuant to the Stipulation.

Thereafter, the conditions of settlement were fulfilled.3

Appellants allege that “[djuring the pen-dency of the settlement, Coram made numerous, materially false and misleading announcements to the investing public regarding its business ventures and financial status, which inflated the market price of its common stock.” These announcements related to the following business activity: In January 1995, Coram announced it would merge with Caremark International; on April 6, 1995, Coram reported the completion of this acquisition; and on April 18, 1995, Coram announced a merger agreement with Lineare. According to appellants,

[i]n early June of 1995, Coram learned that its analysis regarding the value of the consummated Caremark merger was grossly erroneous. As a consequence of this discovery, the pending merger with Lineare was terminated. However, these facts were not disclosed to the plaintiffs or the investing public until late July and early August. Thus, at the very time that plaintiffs and defense counsel were determining the exercise price of the Warrants under the terms of the Stipulation, the defendants knew that the value of the Co-ram stock (which was used to establish th[e] exercise price ... ) was grossly inflated.
Had the plaintiffs and the investing public known 'of the materially adverse information concealed by Coram, the average market price of Coram common stock during the Adjustment Period would have been approximately $5.25 per share, resulting in an Adjusted Exercise Price of approximately $6.30 per share. Instead, on August 11, 1995, the truth surrounding Coram’s financial condition was revealed, and the price of Coram common stock fell dramatically, virtually destroying the value [993] of the Warrants and revealing Coram’s breach of its obligations under the Stipulation.

Appellants’ Br. at 6-8.4

On August 29, 1995, appellants filed a Motion to Enforce Stipulation of Settlement (motion to enforce), alleging, without any accompanying evidentiary support: (1) breach of the covenant of good faith and fair dealing under Georgia law; (2) appellees’ commission of fraud upon the court; and (3) the doctrine of mutual mistake of fact under Georgia law. Appellants requested the following relief:

[Pjlaintiffs move this Court to declare that Coram is in breach of the Stipulation and award the plaintiffs the appropriate measure of damages reflecting the difference in value between 2,520,000 warrants with an exercise price of $20. [25] with Coram at a stock value of $18.50 (the value the day the Settlement Order became Final as defined in the Stipulation) and the same number of warrants in Coram at the same exercise price with Coram at a stock value of $5.25 (the closing price on August 14, 1995, the day following Coram’s August 11 announcement).

Free access — add to your briefcase to read the full text and ask questions with AI

Bender v. Allegra, 130 F.3d 990, 39 Fed. R. Serv. 3d 809, 1997 U.S. App. LEXIS 34315, 1997 WL 753599 (11th Cir. 1997).

130 F.3d 990 (Bender v. Allegra) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related